Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06151236
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-11-21
Brief Title:
Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma
Sponsor:
Melanoma Institute Australia
Organization:
Melanoma Institute Australia
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-04
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-21
First Submit QC Date:
November 21 2023
Study First Post Date:
2023-11-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-14
Last Update Post Date:
2024-03-15
Last Update Post Date Type:
ACTUAL